Project Grant R01NS138924
- This $438,342 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, aims to study the fundamental mechanisms by which ubiquitin ligases recognize and ubiquitinate substrates within protein complexes. The research focuses on understanding the role of the anaphase-promoting complex (APC) in regulating the composition of neuronal...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is providing $127,145 to The Trustees of Princeton University to conduct research dedicated to unraveling the regulatory mechanisms governing chromatin organization and gene transcription during neural development in the Drosophila model organism. The primary focus is on understanding how...
- This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $800,485 to Oregon Health & Science University (OHSU) to investigate the role of human-specific 3D genome conformation in brain development and disease. The key research objectives are to: 1) analyze Hi-C data from cortical neural progenitor cells and neurons derived from human, chimpanzee, orangutan, and rhesus macaque to identify human-specific...
- The National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) awarded a $1,000,000 Project Grant to The Pennsylvania State University to investigate the 3-dimensional structural motifs and molecular mechanisms that direct the folding of chromatin into euchromatin (open, active) and heterochromatin (repressed, condensed) states. This 3-year project will employ cryo-electron tomography to determine the chromatin structures and nucleosome array folding associated with...
- This federal Project Grant award of $264,600.00, provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, supports research to elucidate the mechanisms of HP1B-mediated heterochromatin regulation and the impact of patient-identified CBX1 variants in mouse models of CBX1-related syndrome. The research aims to investigate the role of HP1B, a core structural protein...
- This federal Project Grant award, titled "The Phase Separation of Neuronal Pentraxins: From Synapse Formation to Plasticity", was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program. The $122,526 award supports research at Stanford University to explore a novel mechanism involving liquid-liquid phase separation of neuronal pentraxins and their role in...
- This Project Grant award from the National Science Foundation's (NSF) Mathematical and Physical Sciences (CFDA 47.049) program provides $200,000 in funding to The Trustees of the University of Pennsylvania to conduct collaborative research that aims to understand genomic organization in the cell nucleus. The research team will employ an integrated approach leveraging biophysical modeling, super-resolution imaging, and machine learning to develop predictive models of how chromatin structure and...
- The National Cancer Institute (NCI), under the Cancer Cause and Prevention Research program (CFDA 93.393), awarded a $159,500 Project Grant to the University of California, San Diego (UCSD) to investigate the role of Signal Transducer and Activator of Transcription (STAT) in the initiation of heterochromatin, a tightly packed form of DNA essential for chromosomal compaction, transcriptional silencing, genome stability, and tumor suppression. The 2-year project aims to study the interplay between...
- The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) awarded a $497,689 Project Grant under the Child Health and Human Development Extramural Research program (CFDA 93.865) to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The goal of this 5-year project is to investigate a novel role for actin in ensuring mitotic fidelity during early mammalian development. The researchers will...
- The National Institute of General Medical Sciences (NIGMS) awarded a $408,367 Project Grant to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), under the Biomedical Research and Research Training program (CFDA 93.859). The grant, with a performance period from August 15, 2025 to June 30, 2029, supports research to define an RNA-independent mechanism for the nucleation of heterochromatin formation, a critical process for maintaining genomic stability....
REGULATION OF PHASE SEPARATION IN NEURONAL HETEROCHROMATIN - ABSTRACT ONE OF THE MOST ASTONISHING FEATS IN ALL OF BIOLOGY IS THE PROCESS BY WHICH CHROMATIN, THE COMPLEX OF DNA, HISTONE PROTEINS AND ASSOCIATED FACTORS, BECOMES COMPACTED FROM A LENGTH OF 2 M INTO NUCLEI THAT MEASURE JUST MICRONS ACROSS. UNSURPRISINGLY, OUR UNDERSTANDING OF THE PRINCIPLES THAT GOVERN THIS PROCESS IS IN ITS INFANCY. MY LAB BECAME INTERESTED IN THIS PROCESS AFTER WE IDENTIFIED THE FERGUSON-BONNI ANAPC7 NEURODEVELOPMENTAL SYNDROME CAUSED BY MUTATION OF THE DEGRADATIVE UBIQUITIN LIGASE ANAPHASE-PROMOTING COMPLEX (APC). WE DISCOVERED THAT KI-67 WAS THE MAJOR APC7-DEPENDENT TARGET IN POST-MITOTIC NEURONS, WHERE IT ACCUMULATED IN CONSTITUTIVE HETEROCHROMATIN. SUBSEQUENT EXPERIMENTS IN COMPLEMENTARY MOUSE MUTANTS DEMONSTRATED A MUCH BROADER ROLE FOR THE APC IN REGULATING THE COMPOSITION OF NEURONAL HETEROCHROMATIN, WHERE WE ALSO OBSERVED DRAMATIC ACCUMULATION OF THE CHROMOSOME PASSENGER COMPLEX (CPC) AND ITS PRODUCT PHOSPHORYLATED HISTONE 3 (H3S10PH). LIKE KI-67, THE CONTRIBUTIONS OF THE CPC AND H3S10PH TO NEUROLOGIC DISEASE HAD BEEN PREVIOUSLY UNKNOWN. ALTHOUGH THESE OBSERVATIONS ESTABLISHED AN APC-DEPENDENT UBIQUITINATION-PHOSPHOPROTEIN AXIS IN NEURODEVELOPMENTAL CHROMATIN REGULATION, HOW KI-67 AND H3S10PH CONTROL HETEROCHROMATIN REMAINED POORLY DEFINED. WE HYPOTHESIZE THAT KI-67 AND H3S10PH CONTROL LIQUID-LIQUID PHASE SEPARATION (LLPS), A PHYSICOCHEMICAL PROCESS DRIVEN BY MULTIVALENT INTERACTIONS OF DISORDERED PROTEINS LIKE KI-67 AND PHOSPHOPROTEINS LIKE H3S10PH. STUDIES FROM OTHER LABS SHOWED THAT LLPS OF CONSTITUTIVE HETEROCHROMATIN REQUIRES THE SMALL PROTEIN HP1A, WHICH INTERACTS WITH KI-67. DATA FROM MY LAB SHOWED THAT NEURONAL KI-67 UNDERGOES RAPID RELOCALIZATION AWAY FROM HETEROCHROMATIN UPON DISRUPTION OF LLPS, INDICATING KI-67'S ASSOCIATION WITH CONSTITUTIVE HETEROCHROMATIN REQUIRES LLPS. THIS COMPELLING SERIES OF OBSERVATIONS LEADS US TO THE CENTRAL HYPOTHESIS OF THIS PROPOSAL: LLPS OF HETEROCHROMATIN-ASSOCIATED APC TARGETS IS REQUIRED FOR NEURODEVELOPMENT AND WHEN PERTURBED CONTRIBUTES TO THE PATHOGENESIS OF APC-RELATED NEURODEVELOPMENTAL DISORDERS. IN AIM 1, WE WILL EXPLORE THE ROLE OF KI-67 IN THE FORMATION OF HETEROCHROMATIN IN NEURONS USING IMAGING AND MOLECULAR ANALYSES OF A NOVEL MOUSE MODEL OF KI-67 MUTATION. IN AIM 2, WE WILL EMPLOY ELEGANT IN VITRO ASSAYS TO DETERMINE HOW KI- 67 ENHANCES LLPS OF HP1A AND NUCLEOSOME ARRAYS. IN AIM 3, WE WILL EXPLORE THE LIQUID-LIKE BEHAVIOR OF APC SUBSTRATES KI-67 AND THE CPC BY IMAGING HETEROCHROMATIN DYNAMICS IN LIVE NEURONS. ARMED WITH NOVEL IN VIVO GENETIC SYSTEMS, POWERFUL IN VITRO ASSAYS, AND WORLD-CLASS EXPERTISE IN THE WET LAB AND COMPUTATIONAL METHODS, WE ARE POISED TO GENERATE FUNDAMENTAL INSIGHT INTO CHROMATIN REGULATION BY UBIQUITIN AND LLPS IN NEURONS.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $313.8k | 5/9/25 | ||
| Not listed | $313.8k | 7/23/24 | ||
| Not listed | $313.8k | 7/23/24 |